Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Recent patents report new treatment strategies for respiratory diseases

July 7, 2006

NVA-237 successfully completes phase IIb study in COPD

June 30, 2006

Patent claims use of telithromycin in acute exacerbations of asthma

June 28, 2006

Novartis seeks Japanese approval of Xolair

June 27, 2006

Recordati inlicenses Infasurf for E.U.

June 27, 2006

Enrollment completed in follow-up study for Pollinex Quattro allergy vaccine

June 27, 2006

Recent patents describe therapeutic agents for respiratory disorders

June 23, 2006

Parion Sciences presents novel ENaC blocker as clinical candidate for CF

June 19, 2006

Orphan drug status for Surfaxin in prevention of bronchopulmonary dysplasia

June 19, 2006

Cobalis plans twin phase III studies for PreHistin

June 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...